New York's Life Science Disruptors

New York's Life Science Disruptors

The crowd settles in as the first of our panels gets underway.

New York's Life Science Disruptors

New York's Life Science Disruptors

Acorda Therapeutics CEO Ron Cohen (left), Icahn Institute for Genomics and Multiscale Biology director Eric Schadt (middle), and Rockefeller University president Marc Tessier-Lavigne (right) gave the audience a snapshot of the past, present, and future of New York biotech.

New York's Life Science Disruptors

New York's Life Science Disruptors

Ok, New York City's now a hotbed for wide-ranging academic collaborations, but it didn't used to be that way. What's changed?

New York's Life Science Disruptors

New York's Life Science Disruptors

Meg Tirrell (Bloomberg) and Alex Denner (Sarissa Capital Management) engage in some lighter moments with the crowd.

New York's Life Science Disruptors

New York's Life Science Disruptors

Audience members kept the speakers on their toes.

New York's Life Science Disruptors

New York's Life Science Disruptors

Celgene's senior vice president of business development, George Golumbeski (left), gives some candid thoughts about the mindset at Celgene: "It's deep in the DNA there to take a risk and think outside the box," he says. Francois Nader, who completely overhauled NPS Pharma to keep it alive, looks on.

New York's Life Science Disruptors

New York's Life Science Disruptors

A packed house takes in the event festivities.

New York's Life Science Disruptors

New York's Life Science Disruptors

Post-event networking begins en masse.

New York's Life Science Disruptors

New York's Life Science Disruptors

New connections are made over drinks and discussion.

New York's Life Science Disruptors

New York's Life Science Disruptors

Networking fuel.

New York's Life Science Disruptors

New York's Life Science Disruptors

Attendees share business cards, drinks, and talk life sciences.

New York's Life Science Disruptors

New York's Life Science Disruptors

One attendee catches our sneaky photographer mid-shot.

New York's Life Science Disruptors

New York's Life Science Disruptors

The crowd stayed pretty late, but then again, there was a lot to discuss.

New York's Life Science Disruptors

New York's Life Science Disruptors

Where would you rather be---inside talking biotech, or out in the polar vortex of Manhattan?

A true New York biotech cluster is coming. It’s just going to take some more disruption to get there.

That was one of the big themes I took home when I recapped our latest Big Apple biotech event, “New York’s Life Science Disruptors,” on Monday. The event, which took place last Thursday, March 6, consisted of a lively series of discussions about the state of biotech in the big city, featuring viewpoints from different key contributors to the life sciences ecosystem: academics/researchers, industry players, and investors. Today, I’m circling back with a slideshow look into what was a fun night on East 29th Street (a big thank you to Hana & LaCruz for the photos).

Once again, a special thanks to our speakers and moderators, our event host Alexandria Real Estate Equities, and our sponsors: Halloran Consulting Group and Guard Dog Brand Development.

Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at bfidler@xconomy.com

  • Neil Solomon

    I was a participant at the Life Science Disruptors and was surprised that in the discussion of many of the important institutions in the New York area, no one mentioned Cold Spring Harbor Labs. In fact, Long Island was for the most part omitted entirely .